Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101

Benzinga · 2d ago
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $101.